Skip to main content

Table 2 Demographics

From: The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial

Parameter

 

BEXIDEM

N = 75

BCG

N = 78

Age

   
 

Mean

63

62.8

 

Median

63

64.5

 

Range

43-83

27-83

Sex

   
 

Male

62 (83%)

64(82%)

 

Female

13 (17%)

14 (18%)

Ethnic Group

   
 

Caucasian

75 (100%)

77 (99%)

 

Mediterranean

0 (0%)

1 (1%)